Senior Director, Clinical Regulatory Affairs jobs in United States
cer-icon
Apply on Employer Site
company-logo

Umoja Biopharma · 16 hours ago

Senior Director, Clinical Regulatory Affairs

Umoja Biopharma is an industry-leading biotech focused on transforming cancer treatment with an innovative immunotherapy platform. The Senior Director of Regulatory Affairs will lead regulatory strategies and oversee submissions for drug products, playing a critical role in the development of CAR-T therapy programs.

BiopharmaBiotechnology

Responsibilities

Independently provide regulatory leadership and oversight for ongoing and planned in vivo CAR-T therapy programs
Develop and execute global regulatory strategies to support indication selection, trial design, and endpoints, to support program advancement
Develop registration strategies and plans (e.g., TPP development and assessment) to achieve regulatory approvals and desired product labeling
Lead global regulatory filings (IND/CTA/BLA/MAA submissions), setting strategy for submissions of product registration documents for health authorities worldwide
Primary point of contact with global regulatory agencies to support program advancement
Effectively communicate the regulatory strategy, risks, mitigations and overall plans to Regulatory Affairs, program teams, senior management, and external stakeholders (as relevant)
Identify, communicate, and propose resolutions to both routine and complex issues
Provide regulatory advice and guidance in the context of available and expected scientific data, regulatory guidance, and precedent to project teams to support decision making and program advancement
Collaborate closely with translational medicine, preclinical, clinical, CMC Regulatory, and technical teams to align overall strategy with scientific discoveries. Demonstrate ability to engage and effectively influence team members across multidisciplinary teams
Stay current on emerging trends, competitors, and regulatory guidance in cell & gene therapy and oncology and/or autoimmune therapeutic areas. Conduct regulatory research to assess the impact of relevant global regulations, guidance, and current regulatory environment. Provide interpretation of regulatory authority feedback, policies, guidelines, and directives
Work with external program partners collaboratively and effectively to deliver on contractual obligations while moving toward corporate goals and priorities
Provide organizational support and mentoring as company grows its product development pipeline

Qualification

Regulatory AffairsCell & Gene TherapyOncology Drug DevelopmentRegulatory SubmissionsGlobal Regulatory StrategyLeadership SkillsCommunication SkillsCross-functional CollaborationProblem Solving

Required

PhD/MS/BS in a relevant scientific field required with a minimum of 12/15/15+ years, respectively, of relevant experience in regulatory affairs
Experience in Oncology, Hematology, or related specialty strongly preferred
Successful track record of regulatory submissions and approvals
Demonstrated expertise in cell & gene therapy, ideally with CAR-T or T-cell engaging modalities preferred; experience in in vivo gene delivery a plus
Strong knowledge of global regulatory requirements for early- and late-stage development of gene and cell therapies
Proven ability to interact with regulatory authorities
Excellent communication, leadership, and cross-functional collaboration skills
Passion for innovation and commitment to advancing transformative therapies for patients
Ability to travel (~20%) for team meetings and/or regulatory interactions as required
Ability to sit for prolonged periods of time

Benefits

Medical, Dental, and Vision plans
401k plan through Fidelity, with a 100% match up to their first 4% deferral
Generous Paid Time Off policy
Employee commuter benefits
Cell phone stipend

Company

Umoja Biopharma

twittertwittertwitter
company-logo
Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Funding

Current Stage
Growth Stage
Total Funding
$363M
Key Investors
DCVC Bio
2025-01-14Series C· $100M
2021-06-15Series B· $210M
2020-11-18Series A· $53M

Leadership Team

leader-logo
Ryan Crisman
Co-Founder and Chief Technology Officer
linkedin
Company data provided by crunchbase